<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Warheit, David B.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Debunking Some Misconceptions about Nanotoxicology.</style></title><secondary-title><style face="normal" font="default" size="100%">Nano letters</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010 Oct 29</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://pubs.acs.org/doi/abs/10.1021/nl103432w</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">As research on the possible applications of nanotechnology have made rapid progress, research on the potential negative environmental, health and safety implications of nanotechnology has lagged behind. As a consequence, the success of nanotechnology will require assurances that the products being developed are safe from an environmental, health, and safety standpoint. These concerns have led to a debate among governmental agencies and advocacy groups on whether implementation of special regulations should be required for commercialization of products containing nanomaterials. Therefore the assessments of nanomaterial-related health risks must be accurate and verifiable. In this article, the author briefly discusses some of the generalized &quot;misconceptions&quot; regarding nanomaterial toxicity and presents alternative views on these issues.</style></abstract><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/21033694?dopt=Abstract</style></custom1></record></records></xml>